Insider Transactions in Q3 2021 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Hugh F Johnston Director |
BUY
Grant, award, or other acquisition
|
Direct |
455
+49.46%
|
-
|
|
Aug 05
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
4,018
-100.0%
|
$1,004,500
$250.12 P/Share
|
|
Aug 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
2,500
-12.25%
|
$627,500
$251.91 P/Share
|
|
Aug 03
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
18,093
-12.93%
|
$4,577,529
$253.51 P/Share
|
|
Aug 03
2021
|
A Bruce Moore Jr Group President - Service Line |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+21.14%
|
$1,387,500
$37.18 P/Share
|
|
Aug 03
2021
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
6,000
-1.5%
|
$1,512,000
$252.94 P/Share
|
|
Aug 02
2021
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
3,000
-1.47%
|
$750,000
$250.94 P/Share
|
|
Aug 02
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Indirect |
40,000
-35.26%
|
$10,000,000
$250.01 P/Share
|
|
Aug 02
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
409
-9.24%
|
$101,841
$249.57 P/Share
|
|
Jul 30
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
2,900
-39.58%
|
$722,100
$249.43 P/Share
|
|
Jul 29
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
200
-2.66%
|
$49,800
$249.36 P/Share
|
|
Jul 28
2021
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
200
-0.4%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
23,268
+50.0%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Direct |
20,000
-90.56%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Direct |
20,000
+26.21%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Indirect |
23,268
-65.21%
|
-
|
|
Jul 27
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,782
-38.85%
|
$1,181,154
$247.69 P/Share
|
|
Jul 27
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,800
+31.76%
|
$510,400
$58.47 P/Share
|
|
Jul 27
2021
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
3,000
-1.45%
|
$747,000
$249.94 P/Share
|
|
Jul 27
2021
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
7,466
-36.7%
|
$1,866,500
$250.0 P/Share
|
|
Jul 26
2021
|
Charles J Hall Group President |
SELL
Bona fide gift
|
Direct |
3,270
-1.56%
|
-
|
|
Jul 22
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
886
-9.08%
|
$217,956
$246.9 P/Share
|
|
Jul 21
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
1,000
-5.92%
|
$252,000
$252.0 P/Share
|
|
Jul 21
2021
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,614
-32.09%
|
$2,393,886
$249.25 P/Share
|
|
Jul 21
2021
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,080
+36.31%
|
$1,178,520
$69.58 P/Share
|